Zobrazeno 1 - 10
of 44
pro vyhledávání: '"KELLEDY MANSON"'
Autor:
Mark M. Awad, Ramaswamy Govindan, Kristen N. Balogh, David R. Spigel, Edward B. Garon, Meghan E. Bushway, Asaf Poran, Joong Hyuk Sheen, Victoria Kohler, Ekaterina Esaulova, John Srouji, Suchitra Ramesh, Rohit Vyasamneni, Binisha Karki, Tracey E. Sciuto, Himanshu Sethi, Jesse Z. Dong, Melissa A. Moles, Kelledy Manson, Michael S. Rooney, Zakaria S. Khondker, Mark DeMario, Richard B. Gaynor, Lakshmi Srinivasan
Publikováno v:
Cancer cell. 40(9)
Neoantigens arising from mutations in tumor DNA provide targets for immune-based therapy. Here, we report the clinical and immune data from a Phase Ib clinical trial of a personalized neoantigen-vaccine NEO-PV-01 in combination with pemetrexed, carbo
Autor:
Lakshmi Srinivasan, Yvonne Ware, Kelledy Manson, Asaf Poran, Benjamin Trapp, Joel Greshock, Mark M. Awad, Dominik Barthelme, Dewi Harjanto, Victoria Kohler, Ying S. Ting, Richard B. Gaynor, Yuting Huang, Matthew D. Hellmann, Samantha J. Turnbull, Siwen Hu-Lieskovan, Ed Fritsch, Meghan E. Bushway, Jessica J. Lin, Lisa D. Cleary, Bartosz Chmielowski, Zhengping Huang, Michael S. Rooney, Terence W. Friedlander, Rana H. Besada, Patrick A. Ott, Zakaria S. Khondker, Mark DeMario, Kristen N. Balogh, Aung Naing, Melissa A. Moles, Riley R. Curran, Kim Margolin, Nina Bhardwaj, Tracey E. Sciuto, Jesse Z. Dong, Ramaswamy Govindan, Julian Scherer, Amy Wanamaker
Publikováno v:
Cell. 183(2)
Summary Neoantigens arise from mutations in cancer cells and are important targets of T cell-mediated anti-tumor immunity. Here, we report the first open-label, phase Ib clinical trial of a personalized neoantigen-based vaccine, NEO-PV-01, in combina
Autor:
Yue Sun, Valerie Philippon, Alicia Gomez-Yafal, Jenny G. Parvani, Norman L. Letvin, Phillip D. Markham, Michael S. Wyand, David C. Montefiori, Sampa Santra, Gail P. Mazzara, Dennis Panicali, Kelledy Manson
Publikováno v:
Journal of Virology. 81:8563-8570
As the diversity of potential immunogens increases within certain classes of vectors, the possibility has arisen of employing heterologous prime/boost immunizations using diverse members of the same family of vectors. The present study was initiated
Autor:
Howard L. Kaufman, Ken Cheung, Kelledy Manson, Magalese Voulo, Julie Donovan, Joseph Divito, Dorota Moroziewicz, Karl S. Hurst-Wicker, Gail DeRaffele, David S. Lee, Dennis Panicali, Heidi Hörig, Seth Cohen, Josephine Mitcham, Kate Dolan, Francesco M. Marincola, Ena Wang
Publikováno v:
Journal of Clinical Investigation. 115:1903-1912
Immunotherapy for the treatment of metastatic melanoma remains a major clinical challenge. The melanoma microenvironment may lead to local T cell tolerance in part through downregulation of costimulatory molecules, such as B7.1 (CD80). We report the
Autor:
Kimberly A. Zinnack, Norman L. Letvin, Kristin Beaudry, Alicia Gómez Yafal, Petr O. Ilyinskii, Dennis Panicali, Kelledy Manson, Shawn S. Jackson, Valerie Philippon, Marcelo J. Kuroda, Linda Gritz, Michelle A. Lifton, Gail P. Mazzara
Publikováno v:
Journal of Virology. 79:6554-6559
Poxvirus vaccine vectors, although capable of eliciting potent immune responses, pose serious health risks in immunosuppressed individuals. We therefore constructed five novel recombinant vaccinia virus vectors which contained overlapping deletions o
Autor:
Ronald C. Montelaro, Jacqueline Gillis, Kelledy Manson, Kelly Stefano-Cole, Ussama M. Abdel-Motal, R. Paul Johnson, John D. Altman, Michael S. Wyand, David C. Montefiori
Publikováno v:
Virology. 333(2):226-238
The ability of memory T cells to mount a recall response plays a key role in the ability of vaccinated animals to contain viral challenge. In this study, we intensively monitored the expansion of SIV Gag-specific CD8+ T cells in peripheral blood and
Autor:
Pamela A. Kozlowski, Lara Herrmann, Angela Carville, Anna Aldovini, Mike Piatak, R. Paul Johnson, Shainn Wei Wang, Frederic M.N. Bertley, Gail P. Mazzara, Keith G. Mansfield, Kelledy Manson
Publikováno v:
AIDS Research and Human Retroviruses. 20:846-859
We explored the use of a simian-human immunodeficiency virus (SHIV) DNA vaccine as an effective mucosal priming agent to stimulate a protective immune response for AIDS prevention. Rhesus macaques were vaccinated rectally with a DNA construct produci
Autor:
David B. Weiner, Velpandi Ayyavoo, Dan Conway, Donghui Zhang, Daniel S. Hwang, Jean D. Boyer, Jong J. Kim, Kelledy Manson, Mark L. Bagarazzi, Karuppiah Muthumani
Publikováno v:
Journal of Medical Primatology. 31:179-185
We compared the immunogenicity of plasmid vaccines containing multiple human immunodeficiency virus (HIV) antigens and found that covaccination with plasmids expressing HIV-1 14 kDa vpr gene product profoundly reduces antigen-specific CD8-mediated cy
Autor:
Kesen Dang, Liesl K. Nottingham, Joo-Sung Yang, David B. Weiner, Michael S. Wyand, Waixing Tang, Darren M. Wilson, J. Joseph Kim, Kelledy Manson
Publikováno v:
Oncogene. 20:4497-4506
Prostate specific antigen (PSA) is a widely used marker for prostate cancer, which is secreted by normal prostate cells at low levels, but is produced more substantially by cancer cells. We have previously reported on the use of a DNA vaccine constru
Autor:
J. Joseph Kim, Kelledy Manson, Michael S. Wyand, Daniel J. Lee, Liesl K. Nottingham, Joo-Sung Yang, David B. Weiner, Jean D. Boyer, Kenneth E. Ugen, Mark H. Lee
Publikováno v:
Virology. 285(2):204-217
Multicomponent DNA vaccines were used to elicit immune responses, which can impact viral challenge in three separate rhesus macaque models. Eight rhesus macaques were immunized with DNA vaccines for HIV env/rev and SIV gag/pol and were challenged int